We live in challenging times. Rapid climate change, political upheavals, war, food and water insecurities, potential pandemics and rapid technological advancements have created greater uncertainty and instability. Despite greater spending and advances in medical technology, chronic lifestyle diseases (NCDs) continue to rise year on year. The current model of REACTIVE medicine is no longer working.
“To achieve an integrated care model,” says Dr Riaz Motara, CEO of BrandMed Group, “we have to consider the entire care continuum and link all providers in one solution with data sharing and consent-driven access to health information.”
The current model of fragmented care and funder administered multiple family practitioner networks cannot continue. The existing model is inefficient, siloed, expensive and aims to punish rather than reward better outcomes. Declining family practitioner and specialist numbers, practitioner burnout and declining incomes have contributed to greater apathy and low job satisfaction.
The recently published Health Market Inquiry has made the following key suggestions regarding the future of primary care:
• Care must be outcomes-based
• Practices must be multi-disciplinary in nature
• Practices must be technology-enabled.
The increased demand for value-based, person-centred care has gained momentum at precisely the same time as healthcare costs continue to soar, leaving us with little to no choice but to disrupt age-old models, and shift the conversation from treating to preventing; from prescribing to promoting wellness; from hospital treatment to encouraging home-based care; and from physician focus to patient empowerment.
Dr Riaz Motara reminds us that as mobile devices continue to transform almost every facet of our daily lives, connected health solutions and social media platforms have changed the healthcare landscape and provide new opportunities to connect patients, providers and payers. “Clinicians must catch up and be part of this change. Empowered, engaged e-patients are growing a social movement and spearheading the shift,” says Dr Riaz Motara.
It is now time for a new approach to the entire continuum of care, from screening and diagnosis to standardised management, to promoting adherence and compliance, home monitoring and patient engagement. An ecosystem that connects, and creates an information flow between various providers to deliver personalised, predictive, precise, and preventative patient-centred care with and value-based outcomes.
For more information, contact:
Nicole Glickman, BrandMed Communications Specialist
082 377 0741
For comment, contact:
Riaz Motara, BrandMed CEO
083 650 7807
BrandMed (Pty) Limited, is a leading South African healthcare company. Founded in 2014, BrandMed is world first in developing a unique fully integrated end to end solution to address outcomes and value-based care for patients with chronic lifestyle and Non-Communicable-Diseases (NCDs), including hypertension, diabetes, high cholesterol, asthma and chronic obstructive pulmonary disease.
The BrandMed ecosystem seamlessly integrates a combination of connected solutions across the health continuum for patients, healthcare professionals, practices and institutions, with the aim of delivering personalised, effective patient care.
The BrandMed ecosystem:
Breaking new grounds in managing and treating the cardiometabolic disease epidemic, BrandMed Group integrates medical expertise with next-generation technology into the world’s first end to end cardiovascular risk reduction and treatment approach. With personalised patient care at the heart of its treatment cycle, the BrandMed Group comprises KardioFit (patient home monitoring system), KardioPro (dedicated HCP service), KardioLife (unique anti-inflammatory lifestyle programme), and KardioLytix (real-time actuarial analyses of all data).
Committed to delivering cost-effective, high quality blood testing solutions at point of care that patients and providers can rely on for consistently accurate and actionable information.
Combining pharmacology (the science of drugs) and genomics (the study of genes and their functions), Polygene is dedicated to the testing and understanding of how a patient’s genes will affect their response to medication, thereby enabling doctors to make precision treatment decisions for enhanced efficacy.
Beepd Smart Communicator™
In a paperless age of technology, beepd™ is a Smart Communicator that allows us to engage and deliver education material to patients, direct to the their mobile.
- Link to beepd Smart Communicator https://byo.beepdapp.com/cards/9858100516407714/
- Link to the infomercial https://www.beepdapp.com/infomercial
- website address is www.beepdapp.com
A specialised healthcare marketing and advertising agency that continuously pioneers the most progressive, disruptive and inventive forms of communication to connect with consumers, shift their thinking, and capture their loyalty.
KardioGroup was awarded the prestigious Frost & Sullivan South African Product Line Strategy Leadership, Internet of Medical Things South Africa, award in 2019.